← FDA Drug Approvals (Drugs@FDA)

EPLERENONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WESTMINSTER PHARMS · Approved 2021-10-25

Drug application

FDA Application #

ANDA207842

Application type

Abbreviated New Drug Application (Generic)

Brand name

EPLERENONE

Generic name

EPLERENONE

Active ingredients

EPLERENONE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

WESTMINSTER PHARMS

Manufacturer

Westminster Pharmaceuticals, LLC

First approval

2021-10-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown